Menu

Contributors

Meet some of the people featured in the March 2017 issue of The Scientist.

Mar 1, 2017
The Scientist Staff

IOWA STATE UNIVERSITY, DEPARTMENT OF KINESIOLOGY, COLLEGE OF HUMAN SCIENCES COMMUNICATIONS DEPARTMENTElizabeth Stegemöller began piano lessons at age five and played the French horn in her middle school band as well as in high school, where she also sang in the choir. She had no plans to become a musician, however. Instead, she left for college at the University of Missouri wanting to become a physician, but changed her mind once she started taking courses. “It just wasn’t the right fit for me,” she recalls. She declared a major in biology, but after a good friend introduced her to the concept of music therapy, she decided to add it as a second major. “I didn’t like to perform all that much, so using [music] to help other people was right in line with what I thought was most interesting,” she says. After spending several years as a music therapist, Stegemöller went on to pursue a PhD in neuroscience at Northwestern University. “There are people who have a stroke and can’t speak but can sing, or people who can walk with music but freeze without, and I wanted to figure out how that works,” she says. Currently, she is an associate professor at Iowa State University, where she has combined her two passions: music and the brain. In “Exploring the Mechanisms of Music Therapy,” Stegemöller examines the neuronal mechanisms associated with successful music therapy treatment.


MARTA IWANEKTim Falconer has been a journalist since 1983, and started off writing about computers for a magazine called InfoAge. He became a freelancer in 1985 and in 2001 published his first book, Watchdogs and Gadflies: Activism from Marginal to Mainstream, which was about political activism in Canada. He studied mining engineering and English literature at McGill University, and journalism at Carleton University. Falconer is passionate about music, but has never been able to be a musician. “I always thought I was tone deaf, but I didn’t know what that meant,” he says. He found out in 2011, after visiting an auditory neuroscience lab at the University of Montreal. “After my second singing lesson, I went down to Isabelle Peretz’s lab in Montreal and she gave me the bad news that I was amusic,” he recalls. Unlike most others with his condition, an inability to process pitch that is commonly known as tone deafness, Falconer loves music.  In “How Bad Singing Landed Me in an MRI Machine,” he writes about his experience and the science behind amusia.


GREGOR ELSHOLZIn high school in Toronto, Ontario, Diana Kwon took all the basic sciences—chemistry, physics, and biology—and headed off to undergrad at Queen’s University in Kingston with the intent of studying to become a doctor. “I realized I liked science itself more than the medical side of it,” she recalls, and she changed her focus to research. At Queen’s, she worked with human volunteers, studying their decision-making behavior. In 2012, Kwon enrolled as a master’s student at McGill University in Montreal, where she used functional MRI scans to study how episodic memory changes as people age. But again, she found herself on the wrong path. “Most of my time was spent doing statistical analyses, going through massive data sets,” she recalls. “It was not fun for me.” As Kwon began to think about science journalism as a possible career, she started writing for a student blog, then the McGill newspaper. In 2015, she interned at Fermilab, writing about particle physics, and then at Scientific American MIND. Last year, Kwon moved to Berlin and worked as a full-time freelancer for a year before choosing to join The Scientist as an intern. “I felt like I needed more experience,” she says. “The Scientist offered something different, where I could write about all types of life science and continue to hone my skills.”

You can read Kwon’s contributions to the March issue in the Notebook (here) and Literature (here and here) sections.

July 2019

On Target

Researchers strive to make individualized medicine a reality

Marketplace

Sponsored Product Updates

DeNovoMAX - NRGene's new genomics tool to meet a major agbio need:
DeNovoMAX - NRGene's new genomics tool to meet a major agbio need:
NRGene has launched a new product that aims to empower breeding and maximize agricultural yield as part of the Denovo assembly product suite offered by the company.
Overcoming the Efficiency Challenge in Clinical NGS
Overcoming the Efficiency Challenge in Clinical NGS
Download this white paper to see how an ECS lab serving a network of more than 10,000 healthcare providers integrated QIAGEN Clinical Insight (QCI) Interpret to significantly reduce manual variant curation efforts and increase workflow efficiency by 80%!
Veravas Launches Product Portfolio to Mitigate Biotin Interference and Improve Diagnostic Assay Accuracy
Veravas Launches Product Portfolio to Mitigate Biotin Interference and Improve Diagnostic Assay Accuracy
Veravas, Inc., an emerging diagnostic company, launched a portfolio of products that can improve the accuracy of current diagnostic test results by helping laboratory professionals detect and manage biotin interference in patient samples with VeraTest Biotin and VeraPrep Biotin.
New Data on Circulating Tumor DNA as a Biomarker for Detecting Cancer Progression Presented at 2019 ASCO Annual Meeting
New Data on Circulating Tumor DNA as a Biomarker for Detecting Cancer Progression Presented at 2019 ASCO Annual Meeting
Scientists presented more than 30 abstracts featuring Bio-Rad’s Droplet Digital PCR (ddPCR) technology at the American Society of Clinical Oncology (ASCO) Annual Meeting in Chicago, May 31–June 4.